Cardiac Dysfunction in Patients with Fatty Liver Disease

Abroad (travel likely)Recruiting

Conditions

NAFLD · Cardiac Disease · Fatty Liver · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dr. Madhumita Premkumar, Chandigarh, Chandigarh, India
Contact: Study coordinator (Dr. Madhumita Premkumar, MD) · drmadhumitap@gmail.com · +9101722754777

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Nonalcoholic Fatty Liver Disease · Nonalcoholic Fatty Liver Disease (NAFLD) · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Abroad (travel likely)Recruiting

Nottingham, United Kingdom · Nottingham, United Kingdom

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Nonalcoholic Steatohepatitis (NASH) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Abroad (travel likely)RecruitingPHASE1

Columbia, United States

Prevalence of NAFLD in T1DM Patients

NAFLD · Type 1 Diabetes · Fatty Liver, Nonalcoholic

Abroad (travel likely)Recruiting

Genk, Belgium

Longitudinal Observational Study Of Chinese With NAFLD/NASH

Non-Alcoholic Fatty Liver Disease (NAFLD) · Non-Alcoholic Steatohepatitis (NASH)

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong